» Articles » PMID: 35283102

Arid1a Regulates Bladder Urothelium Formation and Maintenance

Overview
Journal Dev Biol
Publisher Elsevier
Date 2022 Mar 14
PMID 35283102
Authors
Affiliations
Soon will be listed here.
Abstract

Epigenetic regulation of gene expression plays a central role in bladder urothelium development and maintenance. ATPase-dependent chromatin remodeling is a major epigenetic regulatory mechanism, but its role in the bladder has not been explored. Here, we show the functions of Arid1a, the largest subunit of the SWI/SNF or BAF chromatin remodeling ATPase complex, in embryonic and adult bladder urothelium. Knockout of Arid1a in urothelial progenitor cells significantly increases cell proliferation during bladder development. Deletion of Arid1a causes ectopic cell proliferation in the terminally differentiated superficial cells in adult mice. Consistently, gene-set enrichment analysis of differentially expressed genes demonstrates that the cell cycle-related pathways are significantly enriched in Arid1a knockouts. Gene-set of the polycomb repression complex 2 (PRC2) pathway is also enriched, suggesting that Arid1a antagonizes the PRC2-dependent epigenetic gene silencing program in the bladder. During acute cyclophosphamide-induced bladder injury, Arid1a knockouts develop hyperproliferative and hyperinflammatory phenotypes and exhibit a severe loss of urothelial cells. A Hallmark gene-set of the oxidative phosphorylation pathway is significantly reduced in Aria1a mutants before injury and is unexpectedly enriched during injury response. Together, this study uncovers functions of Arid1a in both bladder progenitor cells and the mature urothelium, suggesting its critical roles in urothelial development and regeneration.

Citing Articles

Chromatin modifiers in human disease: from functional roles to regulatory mechanisms.

Nie Y, Song C, Huang H, Mao S, Ding K, Tang H Mol Biomed. 2024; 5(1):12.

PMID: 38584203 PMC: 10999406. DOI: 10.1186/s43556-024-00175-1.


Metabolic changes preceding bladder cancer occurrence among Korean men: a nested case-control study from the KCPS-II cohort.

Han Y, Kim U, Jung K, Lee J, Lee K, Shin S Cancer Metab. 2023; 11(1):23.

PMID: 38053135 PMC: 10696702. DOI: 10.1186/s40170-023-00324-0.

References
1.
Wang J, Batourina E, Schneider K, Souza S, Swayne T, Liu C . Polyploid Superficial Cells that Maintain the Urothelial Barrier Are Produced via Incomplete Cytokinesis and Endoreplication. Cell Rep. 2018; 25(2):464-477.e4. PMC: 6351079. DOI: 10.1016/j.celrep.2018.09.042. View

2.
Heiman M, Kulicke R, Fenster R, Greengard P, Heintz N . Cell type-specific mRNA purification by translating ribosome affinity purification (TRAP). Nat Protoc. 2014; 9(6):1282-91. PMC: 4102313. DOI: 10.1038/nprot.2014.085. View

3.
Sun X, Chuang J, Kanchwala M, Wu L, Celen C, Li L . Suppression of the SWI/SNF Component Arid1a Promotes Mammalian Regeneration. Cell Stem Cell. 2016; 18(4):456-66. PMC: 4826298. DOI: 10.1016/j.stem.2016.03.001. View

4.
Deribe Y, Sun Y, Terranova C, Khan F, Martinez-Ledesma J, Gay J . Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer. Nat Med. 2018; 24(10):1627. DOI: 10.1038/s41591-018-0173-9. View

5.
Garczyk S, Schneider U, Lurje I, Becker K, Vogeli T, Gaisa N . ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?. PLoS One. 2018; 13(8):e0202965. PMC: 6107234. DOI: 10.1371/journal.pone.0202965. View